RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 BAT Improves Clinical Status Preferentially in Patients Not Undergoing CRT
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 12
SP 12
OP 12
DO 10.1177/1559897715593523
UL http://mdc.sagepub.com/content/15/12/12.abstract
AB Baroreceptor activation therapy improves quality of life, exercise capacity, and potentially the burden of heart failure hospitalizations in patients with functional class III heart failure with reduced ejection fraction who are on optimal medical and/or device therapy, with pronounced benefit in patients who are not treated with cardiac resynchronization therapy.